Guidance: Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm.
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm.
Information on coronavirus (COVID-19) for those leading a nomadic way of life.
Guidance for commissioners and service providers for those dependent on drugs or alcohol.
Screening standards for the NHS breast screening programme (BSP).
Instructions on how to submit key performance indicator (KPI) data for the Abdominal Aortic Aneurysm (AAA) Screening Programme.
Annual report and data tables from the UK Focal Point on Drugs on the national prevalence, impact, prevention and treatment of drug use.
Advice for everyone to help stop the spread of coronavirus (COVID-19).
Software suppliers who have participated in the national drug treatment monitoring system (NDTMS) compliance programme and the level of compliance awarded.
This external quality assessment (EQA) scheme is suitable for laboratories in the water testing and clinical microbiology sectors examining hospital tap water.
This external quality assessment (EQA) scheme is suitable for laboratories in the water testing and clinical microbiology sectors.